Continue active refreshing of this index's data?

Continue active refreshing of this index's data?

THEME INDICES

STOXX Global Health & Weight Loss

Index Description

The STOXX Health & Weight Loss indices are comprised of companies that stand to benefit from the immediate need of addressing the rising obesity levels in the global population. The obesity epidemic constitutes one of the most pressing health challenges with a major global economic impact. Therefore, the global focus on fighting obesity can be a driver of enhanced revenues for companies exposed to this theme. Revere (RBICS) data allow a detailed breakdown of the revenue sources of the eligible companies, helping this index to select companies with substantial exposure to "fighting globesity" trend. Furthermore, the index excludes companies that Sustainalytics considers to be non-compliant based on the Sustainalytics Global Standards Screening assessment or to be involved with controversial weapons.

Key facts

  • Index allows targeted investment in the companies associated with the Globesity theme
  • Detailed Revere data helps identify and select companies with a revenue exposure above 50% to sectors related to the Globesity theme
  • Liquidity filter ensures replicability
  • Index integrates ESG considerations
  • The detailed methodology can be found in our rulebooks: www.stoxx.com/rulebooks

Descriptive Statistics

Index Market Cap (USD bn) Components (USD bn) Component weight (%) Turnover (%)
Full Free-float Mean Median Largest Smallest Largest Smallest Last 12 monts
STOXX Global Health & Weight Loss N/A 10.6 0.1 0.0 0.9 0.0 8.8 0.0 22.5
STOXX Developed and Emerging Markets Total Market 102,321.0 87,355.1 7.3 0.7 3,331.4 0.0 3.8 0.0 2.6

Supersector weighting (top 10)

Country weighting

Risk and return figures1

Index returns Return (%) Annualized return (%)
Last month YTD 1Y 3Y 5Y Last month YTD 1Y 3Y 5Y
STOXX Global Health & Weight Loss 8.1 6.9 10.2 -23.2 42.9 N/A N/A 10.3 -8.4 7.4
STOXX Developed and Emerging Markets Total Market 2.4 15.8 23.8 18.9 80.2 N/A N/A 24.2 6.0 12.6
Index volatility and risk Annualized volatility (%) Annualized Sharpe ratio2
STOXX Global Health & Weight Loss N/A N/A 14.9 18.2 18.6 N/A N/A 0.4 -0.6 0.4
STOXX Developed and Emerging Markets Total Market N/A N/A 11.0 14.7 17.4 N/A N/A 1.6 0.3 0.6
Index to benchmark Correlation Tracking error (%)
STOXX Global Health & Weight Loss 0.9 0.7 0.7 0.8 0.8 8.7 10.8 10.7 10.6 10.8
Index to benchmark Beta Annualized information ratio
STOXX Global Health & Weight Loss 0.9 0.9 0.9 1.0 0.9 7.3 -1.0 -1.1 -1.3 -0.4

1For information on data calculation, please refer to STOXX calculation reference guide

2Based on EURIBOR1M

(USD, Gross Return), all data as of August 30, 2024

THEME INDICES

STOXX Global Health & Weight Loss

Fundamentals

Index Price/earnings incl. negative Price/earnings excl. negative Price/book Dividend yield (%)3 Price/sales Price/cash flow
Trailing Projected Trailing Projected Trailing Trailing Trailing
STOXX Global Health & Weight Loss 24.1 30.3 21.0 21.0 5.4 1.2 2.8 27.5
STOXX Developed and Emerging Markets Total Market -0.7 19.4 20.8 20.8 2.9 2.4 1.8 15.4

Performance and annual returns

Methodology

The Global version of the index in derived from STOXX Developed and Emerging Markets Total Market, STOXX China A Total Market (accessible through Stock Connect), STOXX China ADR Total Market, STOXX China P Chips Total Market indices. The Global ex China A index version does not consider China A securities.

Two screens are applied: first, only stocks with a three-month median daily trading volume (MDTV) greater than EUR 1,000,000 are included; second, only companies with revenue exposure of more than 50% to the sectors associated with the theme are selected. Companies that Sustainalytics deems to be non-compliant with the Global Standards Screening or to be involved with controversial weapons are excluded.

The index is weighted proportionally to the free-float market cap of the selected stocks multiplied by their aggregate revenue exposure to themes. Weights are capped s follows: the sum of all weights above 4.5% should not exceed 35%, and no single weight should exceed 8%.

The index composition is reviewed annually and rebalanced quarterly.

Versions and symbols

Index ISIN Symbol Bloomberg Reuters
Gross Return EUR CH0536816751 STXOBEG .STXOBEG
Price EUR CH0536816728 STXOBEP .STXOBEP
Net Return EUR CH0536816793 STXOBEN .STXOBEN
Net Return USD CH0536816785 STXOBEV .STXOBEV
Price USD CH0536816777 STXOBEL .STXOBEL
Gross Return USD CH0536816736 STXOBEU STXOBEU INDEX .STXOBEU

Quick Facts

Weighting Weights are determined proportionally to market cap times the total revenue exposure to relevant RBICS sectors
Cap Factor Sum of weights above 4.5% not to exceed 35%. No single weight to exceed 8%
No. of components Variable
Review frequency Components are reviewed annually, weighting factors are recalculated quarterly
Calculation/distribution dayend
Calculation hours 22:15:00 22:15:00
Base value/base date 100 as of Jun. 18, 2012
History Available as of Jun. 18, 2012
Inception date Apr. 08, 2020
To learn more about the inception date, the currency, the calculation hours and historical values, please see our data vendor code sheet.

THEME INDICES

STOXX Global Health & Weight Loss

Top 10 Components4

Company Supersector Country Weight
Eli Lilly & Co. Health Care USA 8.818%
NOVO NORDISK B Health Care Denmark 7.984%
Nike Inc. Cl B Consumer Products and Services USA 7.178%
ResMed Inc. Health Care USA 5.265%
DEXCOM Health Care USA 4.943%
ADIDAS Consumer Products and Services Germany 4.783%
Asics Corp. Consumer Products and Services Japan 3.784%
Edwards Lifesciences Corp. Health Care USA 3.642%
INSULET Health Care USA 3.506%
FISHER & PAYKEL HLTHCR. Health Care New Zealand 3.276%

3Net dividend yield is calculated as net return index return minus price index return

4Based on the composition as of August 30, 2024